B

한미사이언스

008930KOSPI기타 금융업

55.6 / 100

Reference Date: 2026-04-13

Financial Score20.5 / 40
News Sentiment13.1 / 25
Momentum12.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly up 4.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Hanmi Science operates as a business holding company, generating revenue through equity income from subsidiaries, patent and trademark licensing fees, and healthcare and pharmaceutical wholesale businesses. The company focuses on innovation across medical devices, food, beauty care, and IT solutions, and expanded its portfolio through the 2022 acquisition of Hanmi Healthcare.

Number of Employees

489people

Average Salary

72.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
22.60Industry Average 10.010.0Point

2.3x industry avg (risky)

PBR
2.77Industry Average 0.480.0Point

5.8x industry avg (risky)

ROE
13.09Industry Average 5.517.0Point

2.4x industry avg (excellent)

Debt Ratio
4.83Industry Average 19.368.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.3% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲9.9% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 11.8% (declining, 3yr)

Detailed News Sentiment

11 totalPositive 2Neutral 5Negative 0Average Sentiment Score 53.6

Detailed Momentum

52-week position5.0Point

52w mid range (46%)

Current 38,900Won52-week high 51,90052-week low 27,650
1-month return4.0Point

1m +4.71% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

17 totalPositive 0Neutral 17Negative 0
  • Neutral타인에대한채무보증결정(자회사의 주요경영사항)2026-04-07
  • Neutral주식등의대량보유상황보고서(일반)2026-04-03
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-03
  • Neutral최대주주등소유주식변동신고서2026-04-03
  • Neutral주식등의대량보유상황보고서(일반)2026-04-01